ADAM17‐mediated shedding of EGFR family ligands has been linked to oncogenic KRAS‐induced pancreatic cancer (Ardito et al, 2012), suggesting that other ADAM17 substrates may also contribute to mutant KRAS‐driven LAC. Here, ADAM17 is linked to pancreatic neoplasm.